Application 078734
- Type
- ANDA
- Sponsor
- SUN PHARM INDS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | SUSPENSION;ORAL | 300MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078734-001 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078734-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A078734-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2009-06-26 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078734-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A078734-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A078734-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078734-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078734-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078734-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078734-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078734-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078734-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078734-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078734-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078734-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078734-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078734-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078734-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A078734-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078734-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A078734-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A078734-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A078734-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A078734-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A078734-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078734-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A078734-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A078734-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A078734-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A078734-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A078734-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A078734-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A078734-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A078734-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A078734-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A078734-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A078734-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A078734-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A078734-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A078734-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A078734-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A078734-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A078734-001 | AB | 1 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | NCS HealthCare of KY, LLC dba Vangard Labs | a14b5756-4fd1-4ba7-bc23-e1fa9212a148 | 2026-05-18 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 512ab25c-ea79-1e59-e063-6294a90ae9a0 | 2026-05-06 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Umedica Laboratories USA Inc. | e46d4654-76bc-4c33-ac2b-e89ae11b7697 | 2026-05-05 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 51008af2-39ac-546c-e063-6294a90a758f | 2026-05-04 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Major Pharmaceuticals | 567c0777-9bc5-45a9-ba25-959dd76d0e05 | 2026-04-30 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 50873ef7-3deb-7386-e063-6394a90a9c19 | 2026-04-28 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 87f53c04-075c-4d09-925a-0faeaa14f3f9 | 2026-04-23 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Breckenridge Pharmaceutical, Inc. | 54fb494e-bce4-442d-954a-757f9851e81e | 2026-04-13 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 148b90ba-236a-47cc-b171-22dd7f8f8e0a | 2026-03-20 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | NorthStar RxLLC | 20d826cd-fa4a-4570-9e10-9d7d10fb725b | 2026-03-17 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Advagen Pharma Limited | b0bc10f0-7d1b-4adc-bc59-c48dab58ee5a | 2026-02-24 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Advagen Pharma Ltd. | ab4c1f36-82fa-40a2-a31a-227875d0f382 | 2026-02-04 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 244f9a68-5ab4-46b8-a01f-538572fd3c5f | 2026-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 6d2a6cac-f16b-4e6c-8f75-3afffb0a0f3b | 2026-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Camber Pharmaceuticals, Inc. | fe49a773-562c-4da6-96b7-bba52f4d61e2 | 2026-01-30 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Advagen Pharma Ltd | 4ef6a941-a017-40f2-a50a-ab66c43b3347 | 2026-01-13 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Chartwell RX, LLC | c2affa00-1d57-4d85-8db3-745191b4714d | 2026-01-08 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 47b92168-6832-1e0b-e063-6394a90a079a | 2026-01-06 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Chartwell Governmental & Specialty RX, LLC. | e74bb389-8426-4ffc-a14b-a5990de6d0d4 | 2025-12-26 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Trileptal | OXCARBAZEPINE | Novartis Pharmaceuticals Corporation | 4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b | 2025-12-16 | Warnings, Adverse reactions | OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 63304-653 | Oxcarbazepine | oxcarbazepine | Ranbaxy Pharmaceuticals Inc. | ANDA | Current |